SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending following reports of robust early demand for its recently launched oral Wegovy pill, which is amplified by a regulatory delay for a key competitor's oral obesity treatment. This development gives Novo Nordisk a significant first-mover advantage in the burgeoning oral GLP-1 market, driving community discussion around the drug's "game-changing" potential and the company's strong growth prospects.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

Bitmine Immersion Technologies ($BMNR) is trending following its annual shareholder meeting, where a major equity investment in MrBeast's Beast Industries has ignited sharp debate among investors. While some view this as a strategic 'moonshot' for broad crypto exposure to younger demographics, a significant portion of the community expresses concern over the company's core Ethereum treasury strategy, perceived dilution, and leadership's decisions.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending following a notable price decline, with many in the community debating if the stock is now oversold and undervalued. Despite recent "Strong Buy" ratings from analysts, investors are actively discussing concerns around AI monetization, particularly concerning its OpenAI investments and rising data center infrastructure costs. Attention is now focused on the upcoming earnings report for clarity on its future growth and AI strategy.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk (SNDK) is trending due to reports of significantly increased pricing for its high-capacity 3D NAND and enterprise SSDs, driven by an unprecedented memory supercycle and surging AI-driven demand. The community is observing an "insane" and "unbelievable" rally, with some questioning its parabolic valuation and calling it "meme-like," while others believe it's a leader in the AI build-out and poised for further upside.

Regentis Biomaterials Ltd. engages in the development of tissue repair solutions. It focuses on orthopedic treatments through its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue such as inflamed cartilage and bone tissue. The company was founded by Dror Seliktar and Tal Yehiel on September 1, 2004 and is headquartered in Or-Akiva, Israel.

Regentis Biomaterials Ltd.

Regentis Biomaterials

Regentis Biomaterials ($RGNT) is gaining significant attention due to its extremely low public float and a recently secured U.S. patent for its GelrinC liquid formulation, which many believe was initially overlooked. The community is actively discussing the stock's potential for a strong upward movement, driven by its limited tradable shares and insider lock-up, generating anticipation for increased volume and price action for this recent IPO.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Holdings Inc

The upcoming Investor Day for Ondas Holdings is generating significant buzz, with the community highly anticipating potential announcements regarding a major contract, updated 2026 financial outlook, and a rumored spin-off of its drone division, following a substantial $1 billion capital raise. Investors are keenly watching how this capital and strategic government tenders will impact the company's trajectory, fueling fervent debate between expectations of significant upside and concerns over market manipulation and "sell the news" events. Amidst geopolitical tensions highlighting demand for drone and defense technologies, discussions center on whether Ondas Autonomous Systems can deliver transformative news to solidify its position in the rapidly expanding sector.

Moolec Science SA engages in the development and production of science-based food ingredients. Its products include pet food, animal feed, and dietary supplements. The company was founded by Gastón Paladini, Henk Hoogenkamp, and Martin Salinas in 2020 and is headquartered in George Town, Cayman Islands.

Moolec Science SA

Moolec Science (MLEC) is trending sharply after its recent share consolidation significantly tightened the stock's public float. The community is buzzing with speculation about a potential short squeeze, drawing comparisons to other low-float tickers that have seen explosive gains. Traders view MLEC as a high-risk, high-reward momentum play.

Springview Holdings Ltd. engages in the design and construction of residential and commercial buildings. It involves new construction, reconstruction, alterations, and other general contracting services. The company was founded in 2002 and is headquartered in Singapore.

Springview Holdings Ltd - Ordinary Shares - Class A

Springview Holdings Ltd

Springview Holdings (SPHL) is trending after a massive surge, driven by news of its international expansion into solar-ready homes in Singapore. The community is actively discussing its low-float status and short-squeeze potential, drawing comparisons to other recent parabolic movers, with some traders reporting brokerage limitations on buying.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets and Data Centers. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

Galaxy Digital is trending as the community is highly focused on the recent ERCOT approval to double the power capacity at its Helios data center to over 1.6 GW, a development seen as a significant catalyst for its AI infrastructure play. This move is sparking discussions about GLXY's potential re-rating beyond solely a Bitcoin proxy and the anticipation of new high-profile tenants. Despite some frustration over past performance compared to sector peers, a strong bullish sentiment persists for its long-term position in both AI compute and digital asset markets.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending due to robust Phase 2 data for its obesity drug VK2735 and heightened M&A speculation following Novo Nordisk's CEO expressing openness to multi-billion dollar acquisitions in the weight-loss sector. The community is actively debating VKTX's 

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Scilex (NASDAQ:SCLX) Stock Price Down 3% - Time to Sell?

Scilex (NASDAQ:SCLX) Shares Down 3% - Time to Sell...

Scilex (NASDAQ:SCLX) Stock Price Down 1.3% - Time to Sell?

Scilex (NASDAQ:SCLX) Shares Down 1.3% - What's Next...

<ul class="summary-bullets"><li>The first tranche in September 2025 was $8 million in Bitcoin.</li><li>The second tranche of $141.93 million brings the total investment to $150 million.</li><li>Datavault said the funds will boost digital asset reserves, supercomputing, platform growth, and new revenue streams.</li></ul>Datavault AI (DVLT) announced on Wednesday that it has closed the second tranche of a strategic Bitcoin (BTC)-backed investment from Scilex (SCLX), securing capital to expand its digital asset reserves.In this deal, Scilex used 1,237.6 Bitcoin (BTC) to receive a pre-funded warrant that can be converted into roughly 264 million Datavault shares.&nbsp;In total, Scilex is expected to receive approximately 278.9 million Datavault shares, including 15 million in common stock from the first tranche of investment.The first tranche of the investment, completed in September 2025, was also made in Bitcoin and valued at about $8 million.&nbsp;With the $141.93 million second tranche, the combined investment totals approximately $150 million.&nbsp;Datavault said the investment will help it grow its digital asset reserves, expand supercomputing infrastructure, develop its platform, and create new revenue opportunities.&nbsp;<h2 class="st-heading-2">The Market Reaction</h2>Scilex Holding Company and Datavault partnered in September following Scilex’s $150 million investment. In addition to the capital infusion, Scilex secured a worldwide exclusive license reportedly valued at up to $10 million for Datavault’s AI and tokenization technology, focused on monetizing real-world assets and data, particularly in biotech and healthcare.<a href="https://stocktwits.com/symbol/SCLX">SCLX’s stock</a> dropped as much as 3.65% in pre-market trade despite strength in the broader market. On Stocktwits, it was among the top trending tickers. Data showed retail sentiment around the company rose to ‘extremely bullish’ from ‘bullish’ territory, accompanied by ‘high’ levels of chatter over the past day.&nbsp;<a href="https://stocktwits.com/symbol/DVLT">DVLT’s stock</a> edged 0.4% lower, with retail sentiment around the firm improving to ‘bullish’ from ‘neutral’ over the past day, with chatter at ‘high’ levels.<h2 class="st-heading-2">What Is Retail Thinking?</h2>One bullish user on Stocktwits said Scliex’s position in Datavault is now worth more than the original $150 million investment.&nbsp;<stembedurl>https://stocktwits.com/Sacsofcash/message/637487414</stembedurl>Another bullish trader anticipates ample runway ahead for the stock’s price to gain.<stembedurl>https://stocktwits.com/ToxicAvenger/message/637491996</stembedurl>SCLX’s stock has gained more than 30% this year, while DVLT’s stock has gained almost 10%.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/bitcoin-xrp-ada-struggle-ahead-of-thanksgiving-analyst-warns-no-catalyst/cL53V2sREWP">Bitcoin, XRP, ADA Struggle Ahead Of Thanksgiving – Analyst Warns There’s No Clear Catalyst For Q4</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of Bitcoin with stock market data. (Source: Andriy Onufriyenko/Getty Images)

Scilex Injects More Bitcoin Into Datavault AI, Unlocks 264M Share Warrant Issue

Retail sentiment on Stocktwits around both stocks rose over the past day, despite slight pre-market share price declines.

Equity

<ul class="summary-bullets"><li>Record shareholders of Scilex Holding Company will also be eligible for the meme coin airdrop.</li><li>Datavault AI described the decision as a gesture of appreciation for Scilex’s role as a stockholder, licensing partner, and co-sponsor of Dream Bowl XIV.</li><li>The board retains the right to alter the record date or revoke the airdrop before distribution based on solvency or surplus considerations.</li></ul>Datavault AI (DVLT) traded higher in pre-market hours on Monday after announcing that record shareholders as of today will qualify for its Dream Bowl 2026 meme coin airdrop set for January.<a href="https://stocktwits.com/symbol/DVLT/">DVLT’s stock</a> rose as much as 2.75% in pre-market trade. On Stocktwits, retail sentiment around the company dipped to ‘neutral’ from ‘bullish’ territory over the past day. To qualify for the distribution, holders must own Datavault AI shares as of the record date of November 25, 2025, the company said Friday.<h2 class="st-heading-2">Scilex Equity Holders Included in Airdrop Plan</h2>The company also said the airdrop will extend to record holders of Scilex Holding Company (SCLX) common stock. Datavault AI described the decision as a gesture of appreciation for Scilex’s role as a stockholder, licensing partner, and co-sponsor of Dream Bowl XIV, which is scheduled for January 11, 2026.<a href="https://stocktwits.com/symbol/SCLX">SCLX’s stock</a> rose as much as 18% in pre-market trade but later reversed, moving nearly 5% lower as the market open approached. On Stocktwits, retail sentiment around the stock remained in ‘bullish’ territory, with chatter at ‘high’ levels.<h2 class="st-heading-2">Distribution Terms and Board Discretion</h2>Datavault AI said the Dream Bowl 2026 Meme Coins will be distributed to Data Vault wallets after the payment date, provided recipients elect to opt in, set up a digital wallet, and supply the required documentation.The company added that its Board of Directors may change the record date at any time before the payment date. The distribution remains subject to the Board’s approval and may be revoked, including in the event of a material change to the solvency or surplus analysis previously presented.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/btc-holds-86000-crypto-market-back-above-3-trillion-xrp-doge-gain/cL5bex0REQP">Bitcoin Holds $86,000 With Crypto Market Back Above $3 Trillion – XRP, Doge Gain Ahead Of Grayscale’s New ETF Launches</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Datavault AI logo is seen displayed on a smartphone screen.

DVLT Shares Rise In Pre-Market On Upcoming Meme Coin Distribution For Record Shareholders

Record shareholders as of Monday will be eligible to receive the airdrop, scheduled for January.

Scilex (NASDAQ:SCLX) Posts Earnings Results, Misses Expectations By $21.76 EPS

Scilex (NASDAQ:SCLX - Get Free Report) announced its quarterly earnings results on Friday. The company reported ($22.17) earnings per share (EPS) for the quarter, missing the consensus estimate of...

Scilex Holding Company (SCLX) on Thursday said that its majority-owned subsidiary, Semnur Pharmaceuticals, and Denali Capital Acquisition Corp (DECA) have entered into a purchase agreement with an investor for a $20 million private placement.The proceeds of the <a target="_blank" rel="noopener noreferrer nofollow" href="https://scilexholding.gcs-web.com/node/10161/pdf">agreement</a> will be used to advance the second late-stage clinical trial for the development of SP-102, a viscous gel formulation of a widely used corticosteroid for epidural injections, for the treatment of lumbosacral radicular pain. Lumbosacral radicular pain, often referred to as sciatica, is a pain that radiates along the sciatic nerve, which extends from the lower back down the leg.On Stocktwits, retail sentiment around Scilex remained within the ‘neutral’ territory over the past 24 hours, while message volume fell from ‘normal’ to ‘low’ levels. <a href="https://stocktwits.com/symbol/SCLX">SCLX stock</a> is trading 0.5% lower in the pre-market session at the time of writing.<figure class="image"><img style="aspect-ratio:567/60;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_21_at_7_24_17_AM_png_36aea133ff.webp" alt="SCLX's Sentiment Meter and Message Volume as of 7:24 a.m. ET on Aug. 21, 2025 | Source: Stocktwits" width="567" height="60"><figcaption>SCLX's Sentiment Meter and Message Volume as of 7:24 a.m. ET on Aug. 21, 2025 | Source: Stocktwits</figcaption></figure>Semnur and special purpose acquisition company (SPAC) Denali entered into a <a target="_blank" rel="noopener noreferrer nofollow" href="https://scilexholding.gcs-web.com/node/9226/pdf">plan of merger</a> on Aug. 30, 2024, for a proposed business combination, among Semnur, the SPAC, and the SPAC's unit Denali Merger Sub Inc. This provided for a pre-transaction equity value of Semnur at $2.5 billion.&nbsp;Under the deal, the combined company will be renamed Semnur Pharmaceuticals, Inc., and its common stock is expected to be listed on Nasdaq under the ticker symbol “SMNR”. The combination is now expected to close in September 2025.An investor has agreed to purchase an aggregate of 1.25 million shares of common stock of the combined company following the consummation of the merger transaction, Scilex said. The purchase price for the placement is $16.00 per share, for an aggregate purchase price of $20 million.The closing of the financing is subject to customary conditions and is expected to occur immediately following the consummation of the business combination, Scilex said.The company also said that CEO Jaisim Shah resigned as Scilex CEO and will now serve as chief executive and President of Semnur. Henry Ji, who currently serves as Executive Chairman of Scilex, was appointed as Scilex’s new CEO and President and has assumed all of the duties formerly performed by Shah, the company said.SCLX stock is up by 18% this year and down by 60% over the past 12 months.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/cryptocurrency/two-players-quietly-took-over-bitcoin-mining-power-heres-why-it-matters/chsSu9WRdi5">Two Players Quietly Took Over Bitcoin’s Mining Power — Here’s Why It Matters</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

Scilex Subsidiary Semnur Pharma Eyes $20M Private Placement Deal: More Details Inside

The proceeds of the agreement will be used to advance the second late-stage clinical trial for the development of SP-102, a viscous gel formulation of a widely used corticosteroid for epidural injections, for the treatment of lumbosacral radicular pain.

Scilex Holding Co. (SCLX), a relatively under-the-radar player in the non-opioid pain management space, has unexpectedly captured the attention of retail investors. The company experienced a staggering 41.78% increase in retail followers on Stocktwits over the past month, despite a 21% decline in its share price.However, the initial bullish sentiment has waned, with Stocktwits sentiment flipping to bearish (36/100) and message volumes surging. This shift suggests growing investor skepticism amidst recent company developments.<figure class="image"><img style="aspect-ratio:1316/306;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/SCLX_Sentiment_and_message_score_Aug_1_f79a43cdac.png" alt="SCLX Sentiment and message score Aug 1.png" width="1316" height="306"><figcaption>SCLX Sentiment and message score Aug 1</figcaption></figure>The surge in retail interest can be attributed to several factors. Primarily, the announcement of a potential $2 billion deal for its subsidiary, Semnur Pharmaceuticals, to go public through a SPAC merger with Denali Capital Acquisition Corp (DECA) has generated excitement. The proceeds from this deal are earmarked for the development of SP-102, a key drug candidate in late-stage trials.Additionally, Scilex had reported preliminary Q2 net sales above estimates, indicating revenue growth. However, a significant decline in cash and cash equivalents raised concerns.The company also entered into a collaboration agreement with ACEA for the potential expansion of its ZTlido treatment, used to help relieve nerve pain after shingles, in the Greater China region.While July saw continued sales growth for ZTlido, the pace of growth slowed compared to the previous month. This, coupled with the overall bearish sentiment and declining cash reserves, seems to have tempered initial enthusiasm.With Q2 earnings report scheduled for August 9th after market hours, investors will be closely watching for further clarity on the company's financial health and the progress of its key initiatives.Photo via Vecteezy

Small-Cap Scilex Drew Biggest Jump In Retail Following For July: What Drove It?

Retail investors flocked to Scilex, drawn by news about a lucrative SPAC deal for its unit, declining cash reserves and slowing sales growth.

Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTLido, Elyxyb, and Gloperba. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.

Scilex Holding Company

Short-Term Volatility, Then Markets Move On

Sustained Risk-Off Until Fed Path Is Clear

Little Impact — Fundamentals Still Rule

Other – Comment Below

Markets pulled back after reports that the DOJ opened a criminal investigation into Federal Reserve Chair Jerome Powell, raising concerns about central bank independence. With rate cuts, inflation, and political pressure all in focus, how do you think this standoff will impact markets in 2026?

How Will the Powell Investigation Impact Markets in 2026?

Current Price	$11.67
Prev Close	$12.00
Open	$11.94
Dividend Yield	0.00%
50-Day Moving Average	$16.41
Beta	1.04
Avg. Volume	76,306.00
PE Ratio	-0.35

52-Week High	$34.27
52-Week Low	$3.60
Market Capitalization	$822.72M
EPS (Annual)	-$19.43
Price to Book	-0.39
Revenue Per Employee	$492,086.96
Enterprise Value/EBITDA	N/A

SCLX
Scilex Holding Company

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SCLX News

SCLXScilex Holding Company